Literature DB >> 29451575

Functionalized Cu3BiS3 nanoparticles for dual-modal imaging and targeted photothermal/photodynamic therapy.

Yanke Wang1, Dongdong Cai, Huixia Wu, Yu Fu, Yang Cao, Yingjian Zhang, Dongmei Wu, Qiwei Tian, Shiping Yang.   

Abstract

Multifunctional nano-biomaterials with the integration of diagnostic and therapeutic functions have shown great promise in improving the efficacy of cancer therapy. Herein, a new nanoplatform based on functionalized Cu3BiS3 nanoparticles (NPs) is fabricated for tumour-targeted combination phototherapy. The as-synthesized hydrophobic Cu3BiS3 NPs are modified with DSPE-PEG/DSPE-PEG-NH2, followed by the conjugation of the photosensitizer chlorin e6 (Ce6) and the target ligand folic acid (FA). The introduced Ce6 can further form a chelate complex with Gd3+. The rationally designed Cu3BiS3-PEG-(Ce6-Gd3+)-FA NPs, which have high physiological stability and good biocompatibility, can specifically target FA-receptor over-expressed tumour cells. The Cu3BiS3-PEG-(Ce6-Gd3+)-FA NPs exhibit effective dual-modal CT and MR imaging in the xenografted HeLa tumours. Importantly, excellent in vivo anti-tumour effects have been achieved by synergistic photothermal/photodynamic therapy using the multifunctional NPs. We expect that this versatile nanoplatform will play a role in exploring precise cancer diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29451575     DOI: 10.1039/c7nr07458a

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  8 in total

Review 1.  A Review on the Biodistribution, Pharmacokinetics and Toxicity of Bismuth-Based Nanomaterials.

Authors:  Samireh Badrigilan; Fatemeh Heydarpanahi; Jalal Choupani; Mehdi Jaymand; Hadi Samadian; Mojtaba Hoseini-Ghahfarokhi; Thomas J Webster; Lobat Tayebi
Journal:  Int J Nanomedicine       Date:  2020-09-25

2.  Co-delivery of GOLPH3 siRNA and gefitinib by cationic lipid-PLGA nanoparticles improves EGFR-targeted therapy for glioma.

Authors:  Chengkun Ye; Bomin Pan; Haoyue Xu; Zongren Zhao; Jiawei Shen; Jun Lu; Rutong Yu; Hongmei Liu
Journal:  J Mol Med (Berl)       Date:  2019-11-14       Impact factor: 4.599

3.  Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer.

Authors:  Xiaoyu Li; Shujun Xia; Wei Zhou; Ri Ji; Weiwei Zhan
Journal:  Int J Nanomedicine       Date:  2019-04-05

4.  A new strategy for accurate targeted diagnosis and treatment of cutaneous malignant melanoma: dual-mode phase-change lipid nanodroplets as ultrasound contrast agents.

Authors:  Hengli Yang; Wenbin Cai; Wei Lv; Ping Zhao; Yamei Shen; Longfang Zhang; Bin Ma; Lijun Yuan; Yunyou Duan; Kechun Yao
Journal:  Int J Nanomedicine       Date:  2019-09-02

5.  Optimal fluorescence and photosensitivity properties of dual-functional NaYb1-x F4:Tm x 3+ nanoparticles for applications in imaging guided photodynamic therapy.

Authors:  Zhang Jiayin; Wang Qiyu; Liang Hong; Song Guoli; Zhang Zhiguo
Journal:  RSC Adv       Date:  2021-01-04       Impact factor: 3.361

Review 6.  Development of Novel Tetrapyrrole Structure Photosensitizers for Cancer Photodynamic Therapy.

Authors:  Natalia Plekhova; Olga Shevchenko; Oksana Korshunova; Aleksandra Stepanyugina; Ivan Tananaev; Vladimir Apanasevich
Journal:  Bioengineering (Basel)       Date:  2022-02-19

7.  Self-assembled CeVO4/Au heterojunction nanocrystals for photothermal/photoacoustic bimodal imaging-guided phototherapy.

Authors:  Junrong Wang; Yubo Hu; Junyang Chen; Cong Ye
Journal:  RSC Adv       Date:  2020-01-14       Impact factor: 4.036

8.  A NIR-responsive indocyanine green-genistein nanoformulation to control the polycomb epigenetic machinery for the efficient combinatorial photo/chemotherapy of glioblastoma.

Authors:  Babita Kaundal; Anup K Srivastava; Mohammed Nadim Sardoiwala; Surajit Karmakar; Subhasree Roy Choudhury
Journal:  Nanoscale Adv       Date:  2019-04-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.